Full Press Release Details
Ultragenyx and Kyowa Kirin Announce Crysvita (burosumab-twza) Now Launched in the U.S. for the Treatment of X-linked Hypophosphatemia (XLH) in Children and Adults.
RARE
Ultragenyx and Kyowa Kirin Announce Crysvita (burosumab-twza) Now Launched in the U.S. for the Treatment of X-linked Hypophosphatemia (XLH) in Children and Adults
Key Takeaway: Ultragenyx and Kyowa Kirin Announce Crysvita (burosumab-twza) Now Launched in the U.S. for the Treatment of X-linked Hypophosphatemia (XLH) in Children and Adults